pharma · Paroxysmal Supraventricular Tachycardia · Atrial Fibrillation · MIST
Milestone Pharmaceuticals
Milestone Pharmaceuticals clinical programs — 8 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Montreal, CA
- Founded
- 2007
- Employees
- 123
- Programs
- 8
- Drugs
- 6
- Patents
- 12
Milestone Pharmaceuticals projects
8 ClinicalTrials.gov programs sponsored by Milestone Pharmaceuticals.
Milestone Pharmaceuticals has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
Etripamil
Milestone Pharmaceuticals
Paroxysmal Supraventricular Tachycardia
1 trial -
Etripamil NS
Milestone Pharmaceuticals
Paroxysmal Supraventricular Tachycardia
2 trials -
Etripamil NS 70 mg
Milestone Pharmaceuticals
Paroxysmal Supraventricular Tachycardia
2 trials -
Etripamil NS 70 mg
Milestone Pharmaceuticals
Tachycardia, Supraventricular
1 trial -
Placebo
Milestone Pharmaceuticals
Atrial Fibrillation
1 trial -
Etripamil
Milestone Pharmaceuticals
Paroxysmal Supraventricular Tachycardia (PSVT)
1 trial -
Etripamil
Milestone Pharmaceuticals
Atrial Fibrillation
1 trial -
Etripamil Nasal Spray 70mg
Milestone Pharmaceuticals
Healthy Chinese Subjects
1 trial
Frequently asked questions
How many clinical projects does Milestone Pharmaceuticals have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.